The Institut Pasteur and Fiocruz strengthen their partnership for entrepreneurship

News
|

Committed to shared values, Fiocruz and the Institut Pasteur (Paris) both wish to build on strong entrepreneurship strategies as an innovative way to implement the transfer of a science-based knowledge among society. To discuss the matter, they held a two-day workshop on April 11th and April 12th, on innovation and entrepreneurship, in Rio De Janeiro.

Reinforce an historical partnership

In the framework of their bilateral relations, Fiocruz and the Institut Pasteur (Paris) organized a Two-Day workshop, on April 11th and April 12th  in Rio De Jainero. Indeed, both institutions are historic partners and members of the Pasteur Network which allows them for closer relationship and, for deepening the discussion on several topics such as entrepreneurship. The latter was the main subject of the workshop which highlighted the importance of modern innovation in health and the intersectionality of their innovation and entrepreneurship programs.

This event was therefore a tremendous opportunity to reinforce the institutions cooperation by sharing experiences and strength. The Fiocruz’s new Innovation and Entrepreneurship Program proposal was presented and discussed with the community, in addition to exchanging with the Institut Pasteur (Paris), which carries a greater experience in this area.

Indeed, while Fiocruz is about to launch its Program, the challenges it currently encounters are finding a way for its scientific and research results to reach society. Per tradition, Fiocruz’s scientific results have been incorporated into the health system through its own production and licensing for third parties. Through its new Program Fiocruz aims to disseminate it into society through supporting the creation of technology and science-based companies / spinoffs.

Explore the field of entrepreneurship

To chew over the matter, this encounter was split in two parts. The first day was a virtual workshop live-streamed through the Fiocruz’s YouTube channel (links below) during which both institutions presented their respective innovation and entrepreneurship strategies whereas the second day was held in-person, at the Biomanguinhos Auditorium, at which around 70 persons from Fiocruz participated.

On the first day, both entrepreneurship and innovation strategies were introduced. Marco Krieger, Fiocruz VP of Production and Innovation in Health, and Celeste Emerick, Coordinator of the Entrepreneurship Program, both presented Fiocruz's innovation strategy accompanied by several Fiocruz entrepreneurs. Then, the Institut Pasteur’s innovation model was presented by Dr. Isabelle Buckle, Executive VP Technology Transfer and Industrial Partnership. The model set up at the Institut Pasteur (Paris) aims to develop research applications, in particular the creation of the Institut Pasteur Innovation Accelerator, placed at the center of the Institut Pasteur innovation continuum. The strategy  aims to give new impetus to basic research and increase the impact of this research on health challenges. Michel Perez and Alexandre Batch, both from the Department of Technology Transfer and Industrial Partnership at the Institut Pasteur presented entrepreneurship opportunities in France and the maturation and acceleration programs developed at the Institut Pasteur.

The second day of the workshop was the opportunity to deepen the dialogue regarding innovation and entrepreneurship, the strengths of both programs and challenges they are currently facing. Three sessions were organized. First, the question of “How to go from an invention to an asset” was discussed. Then, issues insuring a “successful transfer of technology to spinoffs “were presented and finally participants conversed on how institutions “can manage the transition from a researcher to an entrepreneur”.

 

 

The second day of the workshop was the opportunity to deepen the dialogue regarding innovation and entrepreneurship, the strengths of both programs and challenges they are currently facing. Three sessions were organized. First, the question of “How to go from an invention to an asset” was discussed. Then, issues insuring a “successful transfer of technology to spinoffs “were presented and finally participants conversed on how institutions “can manage the transition from a researcher to an entrepreneur”.

See the replay of the first day of the workshop in Portuguese or English on the Fiocruz YouTube channel.

À propos :

Fiocruz : Fiocruz is a public and strategic institution of health recognized by the Brazilian society and other countries for its ability to place science, technology, innovation, education and technological production of services and strategic inputs for the promotion of population health, reducing inequalities and social inequalities, the consolidation and strengthening of the Unified Health System (SUS), the formulation and improvement of public health policies.

The values of Fiocruz, featured by the relevance of the performance of the organization to society, are the basis of attitudes, behaviors and characteristics that constitute the essential doctrine of the organization.

Fiocruz wishes to produce, disseminate and share knowledge and technologies which aimed at the strengthening and consolidation of the Unified Health System (SUS) and contribute to the promotion of health and quality of life of the population. Besides the reduction of social inequalities and the national dynamics of innovation, with the defense of the right to health and full citizenship as central values.

Institut Pasteur : The Institut Pasteur, a non-profit foundation with recognized charitable status set up by Louis Pasteur in 1887, is today an internationally renowned center for biomedical research.  In the pursuit of its mission to tackle diseases in France and throughout the world, the Institut Pasteur operates in four main areas: research, public health, training, and development of research applications. The Institut Pasteur is a globally recognized leader in infectious diseases, microbiology, and immunology, with research focusing on the biology of living systems. Among its areas of investigation are emerging infectious diseases, antimicrobial resistance, certain cancers, neurodegenerative diseases, and brain connectivity disorders. The Institut Pasteur's outstanding research is facilitated by the development of a technological environment of the highest standard, with core facilities for nanoimaging, computational biology and artificial intelligence. Since its inception, 10 Institut Pasteur scientists have been awarded the Nobel Prize for Medicine, including two in 2008 for the 1983 discovery of the human immunodeficiency virus (HIV) that causes AIDS.
The Institut Pasteur is part of the Pasteur Network a worldwide network of 33 members on five continents, united by Pasteurian values, that contribute to global health.
Since July 1, 2021, the Institut Pasteur is a research partner organization of Université Paris Cité.

Pasteur Network : Pasteur Network is a worldwide network of 33 members, united by common Pasteurian values, which include humanitarianism, universalism, perseverance, knowledge transmission.
This unique model of cooperation in health brings together, beyond the independent public or private structures that constitute the network, a human and scientific community mobilised on both local and international health priorities in a logic of solidarity.
Pasteur Network members share the missions of biomedical research, public health, training and innovation and technology transfer.
Present in 25 countries worldwide within numerous endemic areas, the Pasteur Network has demonstrated time and time again its role as a major player for the benefit of global health through the One Health approach, actively contributing to improving human health.

 

Subscribe to our newsletter

Back to top